Incidence and outcome of sepsis in Japanese intensive care units: The Japanese nosocomial infection surveillance system

Environmental Health and Preventive Medicine

Volumn 11, Issue 6, 2006, Pages 298-303

  Suka, Machi ^a   Yoshida, Katsumi ^a   Takezawa, Jun ^b  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

ICU; Incidence; Length of stay; Mortality; Sepsis

Indexed keywords

ADOLESCENT; ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; ARTIFICIAL VENTILATION; CALCULATION; CENTRAL VENOUS CATHETERIZATION; CONTROLLED STUDY; DATA BASE; FEMALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; JAPAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PATIENT MONITORING; PROPORTIONAL HAZARDS MODEL; SCORING SYSTEM; SEPSIS; SEX DIFFERENCE; SURVIVAL RATE;

EID: 33751566940     PISSN: 1342078X     EISSN: 13474715     Source Type: Journal    
DOI: 10.1265/ehpm.11.298     Document Type: Article

References (39)

1. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest. 1992;101:1644-1655.
2. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003;31:1250-1256.
3. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001;29:1303-1310.
4. Martin GS, Mannino DM, Eaton S, Moss M. The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med. 2003;348:1546-1554.
5. Brun-Buisson C, Doyon F, Carlet J, Dellamonica P, Gouin F, Lepoutre A, et al. Incidence, risk factors, and outcome of severe sepsis and septic shock in adults: a multicenter prospective study in intensive care units. JAMA. 1995;274:968-974.
6. Sands KE, Bates DW, Lanken PN, Graman PS, Hibberd PL, Kahn KL, et al. Epidemiology of sepsis syndrome in 8 academic medical centers. JAMA. 1997;278:234-240.
7. Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K. Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med. 2003;31:2332-2338.
8. van Gestel A, Bakker J, Veraart CP, van Hout BA. Prevalence and incidence of severe sepsis in Dutch intensive care units. Crit Care. 2004;8:R153-R162.
9. Finfer S, Bellomo R, Lipman J, French C, Dobb G, Myburgh J. Adult-population incidence of severe sepsis in Australian and New Zealand intensive care units. Intensive Care Med. 2004;30:589-596.
10. Silva E, Pedro Mde A, Sogayar AC, Mohovic T, Silva CL, Janiszewski M, et al. Brazilian sepsis epidemiological study (BASES study). Crit Care. 2004;8:R251-R260.
11. Zahorec R, Firment J, Strakova J, Mikula J, Malik P, Novak I, et al. Epidemiology of severe sepsis in intensive care units in the Slovak Republic. Infection. 2005;33:122-128.
12. Adrie C, Alberti C, Chaix-Couturier C, Azoulay E, De Lassence A, Cohen Y, et al. Epidemiology and economic evaluation of severe sepsis in France: age, severity, infection site, and place of acquisition (community, hospital, or intensive care unit) as determinants of workload and cost. J Crit Care. 2005;20:46-58.
13. Vincent JL, Sakr Y, Sprung CL, Ranieri VM, Reinhart K, Gerlach H, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34:344-353.
14. Rangel-Frausto MS. The epidemiology of bacterial sepsis. Infect Dis Clin North Am. 1999;13:299-312.
15. Brun-Buisson C. The epidemiology of the systemic inflammatory response. Intensive Care Med. 2000;26 suppl 1:S64-74.
16. Balk RA. Severe sepsis and septic shock: definitions, epidemiology, and clinical manifestations. Crit Care Clin. 2000;16:179-192.
17. Angus DC, Wax RS. Epidemiology of sepsis: an update. Crit Care Med. 2001;29 suppl 7:S109-116.
18. The 2005 Report of Health and Labour Sciences Research Grant (Research on Emergent or Revival Infections), "Research on network of drug-resistant infection surveillance", 2006. (in Japanese)
19. The 2005 Report of Health and Labour Sciences Research Grant (Research on assessment of medical technology), "Research on prevention of nosocomial infection in intensive care units", 2006. (in Japanese)
20. The 2000 Report of Health and Labour Sciences Research Grant (Research on Emergent or Revival Infections), "Research on development of drug-resistant infection surveillance system", 2000. (in Japanese)
21. Suka M, Yoshida K, Takezawa J. Impact of intensive care unit-acquired infection on hospital mortality in Japan: a multicenter cohort study. Environ Health Prev Med. 2004; 9:53-57.
22. Suka M, Yoshida K, Takezawa J. Association between APACHE II score and nosocomial infections in intensive care unit patients: a multicenter cohort study. Environ Health Prev Med. 2004;9:262-265.
23. Suka M, Yoshida K, Takezawa J. A practical tool to assess the incidence of nosocomial infection in Japanese intensive care units: the Japanese Nosocomial Infection Surveillance System. J Hosp Infect. 2006;63:179-184.
24. Suka M, Yoshida K, Uno H, Takezawa J. Incidence and outcomes of ventilator-associated pneumonia in Japanese intensive care units: the Japanese Nosocomial Infection Surveillance System. Infect Cont Hosp Epidemiol. 2006 (in press).
25. Knaus WA, Draper EA, Wagner DP, Zimmerman JE. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13:818-829.
26. Garner JS, Javis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections 1988. Am J Infect Control. 1988;16:128-140.
27. Jarvis WR, Edwards JR, Culver DH, Hughes JM, Horan T, Emori TG, et al. Nosocomial infection rates in adult and pediatric intensive care units in the United States: National Nosocomial Infections Surveillance System. Am J Med. 1991;91(3B):185S-191S.
28. Cox DR. Regression models and life-tables. J Royal Stat Soc Series B. 1972;34:187-220.
29. Bland JM, Altman DG. Transformations, means, and confidence intervals. BMJ. 1996;312:1079.
30. Bland JM, Altman DG. The use of transformation when comparing two means. BMJ. 1996;312:1153.
31. Turnidge J. Impact of antibiotic resistance on the treatment of sepsis. Scand J Infect Dis. 2003;35:677-682.
32. Shlaes DM, Gerding DN, John JF, Jr, Craig WA, Bornstein DL, Duncan RA, et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis. 1997;25:584-599.
33. Albrich WC, Angstwurm M, Bader L, Gartner R. Drug resistance in intensive care units. Infection. 1999;27 suppl:S19-23.
34. Kollef MH, Fraser VJ. Antibiotic resistance in the intensive care unit. Ann Intern Med. 2001;134:298-314.
35. Yu DT, Black E, Sands KE, Schwartz JS, Hibberd PL, Graman PS, et al. Severe sepsis: variation in resource and therapeutic modality use among academic centers. Crit Care. 2003;7:R24-34.
36. Bodmann KF. Current guidelines for the treatment of severe pneumonia and sepsis. Chemotherapy. 2005;51:227-233.
37. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest. 2000;118:146-155.
38. Weinstein MP, Towns ML, Quartey SM, Mirrett S, Reimer LG, Parmigiani G, et al. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin Infect Dis. 1997;24:584-602.
39. Leibovici L, Shraga I, Drucker M, Konigsberger H, Samra Z, Pitlik SD. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J Intern Med. 1998;244:379-386.